Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pawelec

Showing results (111-120 of 222) with videos related to

Pageof 23
Sort By:
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Partial correction of defective generation of lymphokine-activated killer cells in patients with chronic myelogenous leukaemia after in vivo treatment with interferon-alpha (Wellferon)G Pawelec, E Schneider, G Ehninger, et al.
Immunogenetics|January 1, 1983
SB types of HLA-D homozygous typing cellsP Wernet, S Shaw, C Brautbar, et al.
Cancer Immunology, Immunotherapy : CII|August 12, 2006
CIMT meets strategies for immune therapy. Report and abstracts of the 4th International Meeting of the Association for Immunotherapy of Cancer, Mainz, Germany, 4-5 May 2006C Gouttefangeas, C M Britten, E Derhovanessian Badalians, et al.
International Journal of Immunopharmacology|January 1, 1991
Comparison of the immunosuppressive activities of the antimycotic agents itraconazole, fluconazole, ketoconazole and miconazole on human T-cellsG Pawelec, G Ehninger, A Rehbein, et al.
Immunology|June 1, 1993
Cell-surface expression of human histocompatibility leucocyte antigen (HLA) class II-associated invariant chain (CD74) does not always correlate with cell-surface expression of HLA class II moleculesK M Wilson, M O Labeta, G Pawelec, et al.
Immunology|September 1, 1992
A ligand-epitope in vitro analysis of major histocompatibility determinants expressed on B and T lymphocytesN Fernandez, M Kurpisz, M Labeta, et al.
Human Immunology|July 1, 1981
Restimulation properties of cloned alloactivated lymphocytes: detection of a novel type of HLA-D/DR region determinant and allelic subtypes for HLA-Dw3 using cloned reagentsG Pawelec, A Rehbein, P Kahle, et al.
Transplantation|April 1, 1991
Lack of association between the frequencies of HLA-DR or HLA-DP alleles and the occurrence of chronic graft-versus-host diseaseG Pawelec, C Müller, M Haen, et al.
Transplantation|March 1, 1990
Cytokine regulation of the balance between alloindifferent and allospecific suppressor induction in mixed lymphocyte culturesG Pawelec, P Baumgartner, A Rehbein, et al.
Immunogenetics|January 1, 1983
Homogeneity of the HLA-linked SB2 and SB3 specificities demonstrated by cloned alloreactive T cellsG Pawelec, S Shaw, M Schneider, et al.
Pageof 23

Showing results (111-120 of 222) with videos related to

Sort By:
Pageof 23
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Partial correction of defective generation of lymphokine-activated killer cells in patients with chronic myelogenous leukaemia after in vivo treatment with interferon-alpha (Wellferon)G Pawelec, E Schneider, G Ehninger, et al.
Immunogenetics|January 1, 1983
SB types of HLA-D homozygous typing cellsP Wernet, S Shaw, C Brautbar, et al.
Cancer Immunology, Immunotherapy : CII|August 12, 2006
CIMT meets strategies for immune therapy. Report and abstracts of the 4th International Meeting of the Association for Immunotherapy of Cancer, Mainz, Germany, 4-5 May 2006C Gouttefangeas, C M Britten, E Derhovanessian Badalians, et al.
International Journal of Immunopharmacology|January 1, 1991
Comparison of the immunosuppressive activities of the antimycotic agents itraconazole, fluconazole, ketoconazole and miconazole on human T-cellsG Pawelec, G Ehninger, A Rehbein, et al.
Immunology|June 1, 1993
Cell-surface expression of human histocompatibility leucocyte antigen (HLA) class II-associated invariant chain (CD74) does not always correlate with cell-surface expression of HLA class II moleculesK M Wilson, M O Labeta, G Pawelec, et al.
Immunology|September 1, 1992
A ligand-epitope in vitro analysis of major histocompatibility determinants expressed on B and T lymphocytesN Fernandez, M Kurpisz, M Labeta, et al.
Human Immunology|July 1, 1981
Restimulation properties of cloned alloactivated lymphocytes: detection of a novel type of HLA-D/DR region determinant and allelic subtypes for HLA-Dw3 using cloned reagentsG Pawelec, A Rehbein, P Kahle, et al.
Transplantation|April 1, 1991
Lack of association between the frequencies of HLA-DR or HLA-DP alleles and the occurrence of chronic graft-versus-host diseaseG Pawelec, C Müller, M Haen, et al.
Transplantation|March 1, 1990
Cytokine regulation of the balance between alloindifferent and allospecific suppressor induction in mixed lymphocyte culturesG Pawelec, P Baumgartner, A Rehbein, et al.
Immunogenetics|January 1, 1983
Homogeneity of the HLA-linked SB2 and SB3 specificities demonstrated by cloned alloreactive T cellsG Pawelec, S Shaw, M Schneider, et al.
Pageof 23